THE ROLE OF MICROVASCULAR ULTRASOUND IN THE DIAGNOSIS AND ASSESSMENT OF NEOADJUVANT TREATMENT RESPONSE IN BREAST CANCER

Thu Hương Nguyễn, Thị Phương Thảo Bùi, Ngọc Trung Nguyễn

Main Article Content

Abstract

Objective: To present an overview of microvascular ultrasound (MVUS), including principles, imaging features, and applications in the diagnosis and follow-up after neoadjuvant therapy of breast cancer. Methods: Narrative review, collecting and analyzing recent studies on MVUS. Sources were retrieved from PubMed, Google Scholar, and related medical literature. Results: MVUS allows visualization of very small vessels (<0.1 mm) and slow flow that are difficult to detect with conventional Doppler. Qualitative vascular features on MVUS include: presence or absence of vessels, vascular morphologies (linear, dendritic, root-like, crab-claw). Quantitative index includes the vascular index (VI), calculated as the ratio of pixels with vascular signal to the total number of pixels of the lesion, helping to distinguish benign tumors from breast cancer. Contrast-enhanced MVUS (CEUS) further evaluates perfusion; malignant tumors often show heterogeneous hyperenhancement, perfusion defects, rapid enhancement, etc. Main applications of MVUS include: (1) Differentiating benign and malignant tumors: breast cancers usually show mixed central and peripheral vascular distribution, tortuous vessels, irregular branching, penetrating vessels, uneven diameters; benign tumors often have few vessels, peripheral distribution, straight vessels, regular branching… A high VI generally suggests malignancy, with thresholds reported in the literature around 3–9%. (2) Monitoring neoadjuvant chemotherapy (NAC): reduction in VI, vessel number, diameter, and tortuosity appears early, with potential to predict treatment response or detect drug resistance. MVUS is a non-invasive, repeatable, low-cost method that adds diagnostic value to B-mode ultrasound; however, it still depends on vendor-specific microvascular detection software, and consensus on VI cutoff thresholds is lacking. Conclusion: MVUS is a promising technique, becoming an important component of multiparametric breast ultrasound. Identifying vascular patterns and VI in breast lesions aids differential diagnosis, supports biopsy decisions or follow-up. In NAC monitoring, MVUS contributes to personalized assessment of breast cancer treatment.

Article Details

References

1. Chae EY, Yim HW, Cha JH, Shin HJ, Kim HH. Diagnostic performance of vascular index on superb microvascular imaging in differentiating breast masses. Eur Radiol. 2019;29(7):4119-29.
2. Park AY, Seo BK, Han MR. Breast ultrasound microvascular imaging and radiogenomics. Korean J Radiol. 2021;22(9):1498-510.
3. Kurt SA, Kayadibi Y, Saracoglu MS, Ozturk T, Korkmazer B, Cerit M, et al. Prediction of molecular subtypes using superb microvascular imaging and shear wave elastography in invasive breast carcinomas. Acad Radiol. 2023;30(1):148-57.
4. Park AY, Seo BK. Up-to-date Doppler techniques for breast tumor vascularity: superb microvascular imaging and contrast-enhanced ultrasound. Ultrasonography. 2018;37(2):98-106.
5. Li X, Zhang Y, Wang Y, et al. Contrast-enhanced ultrasound versus B-mode ultrasound in breast cancer diagnosis: a meta-analysis. Medicine (Baltimore). 2020;99(34):e21594.
6. Cai S, Wang H, Zhang X, et al. Superb microvascular imaging technology can improve the diagnostic efficiency of the BI-RADS system. Front Oncol. 2021;11:664257.
7. Zhong L, Wang C, Liu H, et al. Diagnostic accuracy of ultrasound superb microvascular imaging for breast tumor: a meta-analysis. Med Ultrason. 2020;22(3):313-8.
8. Eun Young Chả et al. Added Value of the Vascular Index on Superb Microvascular Imaging for the Evaluation of Breast Masses. Journal of Ultrasound in Medicine; 2020
9. Lee EJ, Chang YW. Prediction of complete response after neoadjuvant chemotherapy for invasive breast cancers: the utility of shear wave elastography and superb microvascular imaging in pretreatment breast ultrasound. Eur J Radiol. 2024;175:111432.
10. Sabeti S, Larson NB, Boughey JC, Stan DL, Solanki MH, Fazzio RT, et al. Ultrasound-based quantitative microvasculature imaging for early prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Breast Cancer Res. 2025;27:24